CORT · Categories · Upgrades

CORT - Analyst upgrades

Corcept Therapeutics Incorporated (CORT) analyst upgrades - real-time wire coverage filtered to Upgrades only.

Recent Upgrades for CORT

• 36d
  Corcept Therapeutics upgraded by UBS with a new price target

  UBS upgraded Corcept Therapeutics from Neutral to Buy and set a new price target of $72.00
• 84d
  Corcept Therapeutics upgraded by Wolfe Research

  Wolfe Research upgraded Corcept Therapeutics from Underperform to Peer Perform
• 955d
  Corcept Therapeutics upgraded by Truist with a new price target

  Truist upgraded Corcept Therapeutics from Hold to Buy and set a new price target of $38.00 from $29.00 previously
• 1422d
  Corcept Therapeutics upgraded by Jefferies with a new price target

  Jefferies upgraded Corcept Therapeutics from Hold to Buy and set a new price target of $35.00 from $21.00 previously

Other CORT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings